Company Filing History:
Years Active: 2025
Title: An Tang - Innovator in Cancer Treatment
Introduction
An Tang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of cancer treatment through his innovative work on chimeric antigen receptors.
Latest Patents
An Tang holds a patent for "Anti-DLL3 chimeric antigen receptors and uses thereof." This patent focuses on the development of anti-DLL3 chimeric antigen receptors (CARs) and DLL3 binding proteins. These innovations are aimed at treating DLL3 associated disorders, particularly small cell lung cancer.
Career Highlights
An Tang is currently employed at Legend Biotech Ireland Limited, where he continues to advance research in the field of immunotherapy. His work is pivotal in the development of targeted therapies for cancer patients.
Collaborations
An Tang collaborates with notable colleagues, including Tao Zhao and Yuanyuan Peng, to further enhance the research and application of his inventions.
Conclusion
An Tang's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a key figure in the field of medical research. His work continues to inspire advancements in the fight against cancer.